343 related articles for article (PubMed ID: 31932479)
1. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
[TBL] [Abstract][Full Text] [Related]
2. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression.
Liu L; Long H; Wu Y; Li H; Dong L; Zhong JL; Liu Z; Yang X; Dai X; Shi L; Ren M; Lin Z
Cell Signal; 2018 Oct; 50():90-99. PubMed ID: 29958993
[TBL] [Abstract][Full Text] [Related]
3. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.
Yang Q; Chen X; Zhang Y; Hu S; Hu F; Huang Y; Ma T; Hu H; Tian H; Tian S; Ji YX; She ZG; Zhang P; Zhang XJ; Hu Y; Yang H; Yuan Y; Li H
Hepatology; 2021 Dec; 74(6):3018-3036. PubMed ID: 34272738
[TBL] [Abstract][Full Text] [Related]
4. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
5. HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.
Xu YM; Wang HJ; Chen F; Guo WH; Wang YY; Li HY; Tang JH; Ding Y; Shen YC; Li M; Xuan WY; Liu LH; Wang J; Wang XR; Gao ZJ; Liang XB; Su DM
Oncotarget; 2015 Dec; 6(40):42854-67. PubMed ID: 26536657
[TBL] [Abstract][Full Text] [Related]
6. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradation.
Chung C; Yoo G; Kim T; Lee D; Lee CS; Cha HR; Park YH; Moon JY; Jung SS; Kim JO; Lee JC; Kim SY; Park HS; Park M; Park DI; Lim DS; Jang KW; Lee JE
Biochem Biophys Res Commun; 2016 Oct; 479(2):152-158. PubMed ID: 27475501
[TBL] [Abstract][Full Text] [Related]
8. HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation.
Zeng C; Guo J; Wu J; Che T; Huang X; Liu H; Lin Z
J Biol Chem; 2023 Jun; 299(6):104723. PubMed ID: 37075843
[TBL] [Abstract][Full Text] [Related]
9. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.
Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH
Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353
[TBL] [Abstract][Full Text] [Related]
10. miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
Jiang K; Shen M; Chen Y; Xu W
Oncol Rep; 2018 Aug; 40(2):943-951. PubMed ID: 29901178
[TBL] [Abstract][Full Text] [Related]
11. HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation.
Wang Y; Wang S; Zhang W
Cell Cycle; 2023 May; 22(9):1116-1126. PubMed ID: 36809917
[TBL] [Abstract][Full Text] [Related]
12. HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*.
Schiedel M; Lehotzky A; Szunyogh S; Oláh J; Hammelmann S; Wössner N; Robaa D; Einsle O; Sippl W; Ovádi J; Jung M
Chembiochem; 2020 Dec; 21(23):3371-3376. PubMed ID: 32672888
[TBL] [Abstract][Full Text] [Related]
13. HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer.
Guo X; Wang A; Wang W; Wang Y; Chen H; Liu X; Xia T; Zhang A; Chen D; Qi H; Ling T; Piao HL; Wang HJ
Mol Oncol; 2021 Feb; 15(2):642-656. PubMed ID: 33207079
[TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase SIRT2 stabilizes Myc oncoproteins.
Liu PY; Xu N; Malyukova A; Scarlett CJ; Sun YT; Zhang XD; Ling D; Su SP; Nelson C; Chang DK; Koach J; Tee AE; Haber M; Norris MD; Toon C; Rooman I; Xue C; Cheung BB; Kumar S; Marshall GM; Biankin AV; Liu T
Cell Death Differ; 2013 Mar; 20(3):503-14. PubMed ID: 23175188
[TBL] [Abstract][Full Text] [Related]
15. Role of the E3 ubiquitin ligase HRD1 in the regulation of serotonin transporter function.
Taguchi K; Kaneko M; Motoike S; Harada K; Hide I; Tanaka S; Sakai N
Biochem Biophys Res Commun; 2021 Jan; 534():583-589. PubMed ID: 33243462
[TBL] [Abstract][Full Text] [Related]
16. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.
Queisser MA; Dada LA; Deiss-Yehiely N; Angulo M; Zhou G; Kouri FM; Knab LM; Liu J; Stegh AH; DeCamp MM; Budinger GR; Chandel NS; Ciechanover A; Iwai K; Sznajder JI
Am J Respir Crit Care Med; 2014 Sep; 190(6):688-98. PubMed ID: 25118570
[TBL] [Abstract][Full Text] [Related]
17. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
18. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
19. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
Yu L; Dong L; Li H; Liu Z; Luo Z; Duan G; Dai X; Lin Z
Oncogene; 2020 May; 39(22):4450-4464. PubMed ID: 32361710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
